Are your residents who do not have dementia excessively sleepy during the daytime? If so, then they may be at risk for an increased accumulation of a brain protein that is a biomarker for Alzheimer’s...
An easier and cheaper way to diagnose Alzheimer’s disease may be on the way
By
John O'Connor
Mar 04, 2020
A simple blood test might soon be all that’s needed to confirm Alzheimer’s disease and frontotemporal dementia.
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.
Eligibility limited for anti-β amyloid mAbs in seniors with MCI
Aug 18, 2023
Few older adults with mild cognitive impairment or mild dementia were eligible for lecanemab or aducanumab after applying clinical trial criteria.
New report calls for more research on women’s health issues
Jul 12, 2024
The National Academies of Sciences, Engineering and Medicine analysis noted that women are disproportionately affected by chronic illnesses, including Alzheimer’s disease, depression and osteoporosis.
Natural environments may cut hospitalization for patients with neurodegenerative diseases
Dec 30, 2022
The normalized difference vegetation index was negatively associated with hospitalization for Alzheimer’s disease and related dementia as well as Parkinson’s disease.
Senior living community trains first responders to ‘take it down a notch’ through dementia education
By
Kimberly Bonvissuto
Jul 07, 2021
After witnessing a troubled interaction between a young police officer and a man with dementia, one senior living community offered to train first responders on communication techniques to increase successful...
More news for Thursday, Feb. 16
Feb 15, 2017
Crash test dummies are being altered to match aging, heavier population … Alzheimer’s outlook far from bleak … Seven couples renew vows at assisted living community for Valentine’s...
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Alzheimer’s diagnosis may lead to reduced social activity: study
By
Amy Novotney
Nov 30, 2021
Despite the belief that early diagnosis of Alzheimer’s disease is crucial, a new study by scientists at Rutgers University suggests that a person’s social network and social support do not increase...